Optical imaging of the whole-body to cellular biodistribution of clinical-stage PEG-b-pHPMA-based core-crosslinked polymeric micelles-Reference-Cited by-同舟云学术

Optical imaging of the whole-body to cellular biodistribution of clinical-stage PEG-b-pHPMA-based core-crosslinked polymeric micelles

Published:2020-12 Issue: Volume:328 Page:805-816
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Biancacci Ilaria,Sun Qingxue,Möckel Diana,Gremse Felix,Rosenhain Stefanie^ORCID,Kiessling Fabian^ORCID,Bartneck Matthias,Hu Qizhi,Thewissen Marielle,Storm Gert,Hennink Wim E.,Shi Yang,Rijcken Cristianne J.F.,Lammers Twan^ORCID,Sofias Alexandros Marios^ORCID

Funder

European Research Council

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference41 articles.

1. Nanocarriers as an emerging platform for cancer therapy;Peer;Nat. Nanotechnol.,2007

2. Nanoparticles in the clinic: an update;Anselmo;Bioeng. Transl. Med.,2019

3. Block copolymer micelles in nanomedicine applications;Cabral;Chem. Rev.,2018

4. Polymer–drug conjugates: origins, progress to date and future directions;Kopeček;Adv. Drug Deliv. Rev.,2013

5. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects;Maeda;Bioconjug. Chem.,2010

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress in stimuli-responsive polymeric micelles for targeted delivery of functional nanoparticles;Advances in Colloid and Interface Science;2024-08

2. Sustained and Localized Drug Depot Release Using Radiation‐Activated Scintillating Nanoparticles;Advanced Materials;2024-03-08

3. Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications;Materials Today Bio;2024-02

4. Co-assembly of polymeric conjugates sensitizes neoadjuvant chemotherapy of triple-negative breast cancer with reduced systemic toxicity;Acta Biomaterialia;2024-02

5. Emergence and impact of theranostic‐nanoformulation of triple therapeutics for combination cancer therapy;Smart Medicine;2024-01-30